Methylamine

Methylamine

SCHEMBL4437029

CN.c1ccc(CN2C3CCCCC2CC3)cc1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.53
CHRM4 P08173 1/20 0.53
CHRM5 P08912 1/20 0.53
HRH3 Q9Y5N1 1/20 0.52
ALDH1A1 P00352 2/20 0.51
LMNA P02545 1/20 0.49
KMT2A Q03164 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
USP2 O75604 1/20 0.47
OPRK1 P41145 3/20 0.46
SIGMAR1 Q99720 1/20 0.45
KCNH2 Q12809 3/20 0.45
OPRM1 P35372 1/20 0.45
OPRD1 P41143 1/20 0.45
ACHE P22303 1/20 0.44
CHRNB2 P17787 1/20 0.44
CHRNA7 P36544 1/20 0.44
CHRNA4 P43681 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL18049528 0.92 CHRM2 (0.56) CHRM2CHRM4CHRM5HRH3ALDH1A1
SCHEMBL5728905 0.90 CHRM2 (0.58) CHRM2CHRM4CHRM5HRH3ALDH1A1
SCHEMBL1723411 0.90 CHRM2 (0.58) CHRM2CHRM4CHRM5HRH3ALDH1A1
SCHEMBL4870895 0.88 CHRM2 (0.60) CHRM2CHRM4CHRM5HRH3ALDH1A1
SCHEMBL20483452 0.88 CHRM2 (0.64) CHRM2CHRM4CHRM5HRH3ALDH1A1
Ammonia Solution, Strong SCHEMBL8187341 0.86 CHRM2 (0.58) CHRM2CHRM4CHRM5HRH3ALDH1A1
SCHEMBL10721099 0.80 HRH3 (0.46) CHRM2CHRM4CHRM5HRH3ALDH1A1
SCHEMBL20967986 0.79 CHRM2 (0.54) CHRM2CHRM4CHRM5ALDH1A1LMNA
SCHEMBL9023345 0.79 CHRM2 (0.54) CHRM2CHRM4CHRM5ALDH1A1LMNA
SCHEMBL15425876 0.79 KMT2A (0.54) CHRM2CHRM4CHRM5ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118109-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Bristol-Myers Squibb Company (US) 2009-11-18 EP disclosed
WO-2008112473-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2008-09-18 WO disclosed